Efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.
about
Short acting insulin analogues versus regular human insulin in patients with diabetes mellitusShort acting insulin analogues versus regular human insulin in patients with diabetes mellitusEfficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysisInsulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical ExperienceAdenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy.An Achilles' heel in an amyloidogenic protein and its repair: insulin fibrillation and therapeutic designComparison of continuous subcutaneous insulin infusion and insulin glargine-based multiple daily insulin aspart injections with preferential adjustment of basal insulin in patients with type 2 diabetes.An estimation of the long-term clinical and economic benefits of insulin lispro in Type 1 diabetes in the UK.Hospitalization of elderly diabetic patients: characteristics, reasons for admission, and gender differences.Indoor air pollution and its association with poor lung function, microalbuminuria and variations in blood pressure among kitchen workers in India: a cross-sectional study.Insulin aspart: a review.Unexplained hyperglycemia in continuous subcutaneous insulin infusion: evaluation and treatment.Novel Insulin Delivery Technologies in Women with Pregestational Type 1 Diabetes: A Review of the Literature.Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.Hypoglycemia in insulin-treated diabetes: a case for increased vigilance.Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusionStability and performance of rapid-acting insulin analogs used for continuous subcutaneous insulin infusion: a systematic review.Moving toward the ideal insulin for insulin pumps.Safety of Insulin Lispro and a Biosimilar Insulin Lispro When Administered Through an Insulin Pump.Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 Diabetes.Insulin analogues versus human insulin in type 1 diabetes: direct and indirect meta-analyses of efficacy and safety
P2860
Q24246142-4CD3A5EC-68E9-4EB6-BED6-60F8E3A003A3Q24246326-2D1EF946-D3EB-441C-A117-4754510C0F1DQ24656013-3D55C85C-BD42-487C-811A-4737539FC899Q28085428-FF347738-BB7D-4BFB-8BA8-1B79078DD9FCQ30438880-D4B54813-C2AD-4888-AFB9-23649CB62EC6Q30494140-BA452E43-FB13-4C37-8F91-152FB3C78A2FQ34119580-2C6951D1-19BD-4C1B-985A-1FDB73A3012CQ35585217-36FE8846-EE1A-4DEE-B772-A6CC5F388EB2Q36123103-C9BA43C6-5822-49AD-9CCD-79247C5F4D91Q36334843-A3425048-2891-460D-9296-BD2AED454B78Q36609772-65C1000B-0DE3-4365-A487-D6D3D4779C70Q37122884-31E9DC21-737E-4717-8A6A-6D8F8DCBCAD2Q37315361-3DCDD40C-45A8-4C0F-84B3-EDE307E00C06Q37595832-39C7CBD0-BE5D-4F2C-8E60-26C5E36E24F2Q37890785-0CA85F6D-A72E-48D6-9DE6-003E996E41F9Q38037730-5FA47037-BE05-43CE-93B0-FD67351F423AQ38172313-AB415CF7-A388-40E3-91E7-755670E13311Q38631154-6D0B9D98-0FF4-4455-8234-285E325CCBE9Q49851108-77FA8D26-DBDB-4556-AFF4-8A364B690B62Q50054965-DC738948-C78F-4763-8B7F-516778E7A508Q57547619-CE7FF072-F242-442F-82E8-1AF77E002C5E
P2860
Efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Efficacy, safety, and pump com ...... patients with type 1 diabetes.
@ast
Efficacy, safety, and pump com ...... patients with type 1 diabetes.
@en
type
label
Efficacy, safety, and pump com ...... patients with type 1 diabetes.
@ast
Efficacy, safety, and pump com ...... patients with type 1 diabetes.
@en
prefLabel
Efficacy, safety, and pump com ...... patients with type 1 diabetes.
@ast
Efficacy, safety, and pump com ...... patients with type 1 diabetes.
@en
P356
P1433
P1476
Efficacy, safety, and pump com ...... patients with type 1 diabetes.
@en
P2093
P356
10.2337/DIACARE.24.1.69
P407
P577
2001-01-01T00:00:00Z